This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Crippling Cost Of Pharmaceuticals In The USA At Global Highs And Still Rising

The cost of pharmaceutical drugs in the USA is already high - Americans pay over 50 percent more for drugs than patients elsewhere in the world - and costs are continuing to rise. However, now there are alternatives to purchasing expensive prescription drugs from local American pharmacies.

CINCINNATI, OH, July 9, 2013 /PRNewswire/ - Americans are already paying more for pharmaceutical drugs than patients anywhere else in the world, and these prices are only expected to rise. The average American will spend $1000 on prescription drugs each year; Americans suffering from chronic illnesses and Americans over the age of 65 will pay even more than this each year.

European patients pay far less for prescription medication. Eldepryl, a drug sometimes prescribed to patients with Parkinson's, costs $28 in Italy and $48 in Austria. American patients prescribed this same medication can expect to pay $240. A 2013 study found that Americans pay 54 percent more than Europeans for 25 of the most commonly prescribed medications.

These cripplingly high costs are only expected to increase, and they are increasing at a faster rate than any other medical expenses. This is partly due to the increased cost of medical technologies, the fact that there is no national health plan in the USA and that the USA lets pharmaceutical companies decide for themselves what they will charge.

It is the elderly and the chronically ill who suffer most from these prices, which is why many patients have begun to get their prescriptions from Canadian pharmacy websites such as allows Americans to save up to 80 percent on the prescription medication that they require. Low costs, high quality and doctor-patient confidentiality ensure that all patients' needs are met without burning a hole in their wallet.


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.60%
FB $117.44 -0.95%
GOOG $692.33 -0.84%
TSLA $232.12 -4.00%
YHOO $36.02 -1.40%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs